CONTEXT THERAPEUTICS INC. Proceeds from Common Stock Issued
CONTEXT THERAPEUTICS INC. (CNTX) reported Proceeds from Common Stock Issued of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-05
- CONTEXT THERAPEUTICS INC. proceeds from issuance of common stock for the quarter ending 2026-06-30 was $0.00.
- CONTEXT THERAPEUTICS INC. proceeds from issuance of common stock for the quarter ending 2026-03-31 was $0.00.
- CONTEXT THERAPEUTICS INC. proceeds from issuance of common stock for the quarter ending 2025-12-31 was $0.00.
- CONTEXT THERAPEUTICS INC. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $15.27K.
- CONTEXT THERAPEUTICS INC. proceeds from issuance of common stock for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CONTEXT THERAPEUTICS INC. proceeds from issuance of common stock for fiscal 2024 was $14.54M.
- CONTEXT THERAPEUTICS INC. proceeds from issuance of common stock for fiscal 2023 was $0.00.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 6 month as first filed | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $15.27K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $15.27K derived: sum of 3 quarters · filed 2026-05-06 | $15.27K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $15.27K derived: sum of 2 quarters · filed 2026-03-23 | $15.27K derived: sum of 3 quarters · filed 2026-08-05 | $0.00 10-K · filed 2026-03-23 | |
| 2025-09-30 | $15.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $15.27K derived: sum of 2 quarters · filed 2026-08-05 | $0.00 10-Q · filed 2025-11-05 | -$80.22M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$15.27K 10-Q · filed 2026-08-05 | $0.00 10-Q · filed 2025-08-06 | -$80.24M derived: sum of 3 quarters · filed 2026-08-05 | -$80.28M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$15.27K 10-Q · filed 2026-05-06 | -$80.24M derived: sum of 2 quarters · filed 2026-05-06 | -$80.28M derived: sum of 3 quarters · filed 2026-05-06 | ||
| 2024-12-31 | -$80.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$80.27M derived: sum of 2 quarters · filed 2026-03-23 | $14.54M 10-K · filed 2026-03-23 | ||
| 2024-09-30 | -$44.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $94.76M 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | $94.80M 10-Q · filed 2025-08-06 | ||||
| 2023-12-31 | $0.00 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |